Immuron shares fall 10.92% intraday amid concerns over high financial risk and unprofitability despite DoD-funded research progress.

Immuron fell 10.92% intraday following the announcement of a proposed securities issue to raise capital by issuing 45.47 million ordinary shares. While the company cited the initiative as a means to strengthen its market position and capital base, such large-scale dilution is often perceived negatively by investors, triggering immediate selling pressure. The move contrasts with recent positive developments, including a U.